Increased NADPH-Oxidase Activity and Nox4 Expression during Chronic Hypertension Is Associated with Enhanced Cerebral Vasodilatation to NADPH In Vivo

Stroke

Volumn 35, Issue 2, 2004, Pages 584-589

  Paravicini, Tamara M ^a   Chrissobolis, Sophocles ^a   Drummond, Grant R ^a   Sobey, Christopher G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cerebrovascular disorders; Hypertension; Pharmacology; Potassium channels; Vasodilation

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DIETHYLDITHIOCARBAMIC ACID; DIPHENYLIODONIUM SALT; ENZYME INHIBITOR; GLYCOPROTEIN GP 91; HYDROGEN PEROXIDE; ISOENZYME; LUCIGENIN; MESSENGER RNA; NOX1 PROTEIN; NOX4 PROTEIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN P22; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER; SUPEROXIDE; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY TONE; ARTICLE; BASILAR ARTERY; BIOSYNTHESIS; BRAIN ARTERY; BRAIN BLOOD FLOW; CEREBROVASCULAR DISEASE; CHANNEL GATING; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME MECHANISM; ENZYME SUBUNIT; GENE EXPRESSION; HYPERTENSION; IN VIVO STUDY; ISOLATED ARTERY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION; VASODILATATION;

ANIMALS; BASILAR ARTERY; CATALASE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HYDROGEN PEROXIDE; HYPERTENSION; MALE; NADP; NADPH OXIDASE; POTASSIUM CHANNEL BLOCKERS; PROTEIN SUBUNITS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RNA, MESSENGER; SPECIES SPECIFICITY; SUPEROXIDE DISMUTASE; SUPEROXIDES; VASODILATION;

EID: 0842289183     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000112974.37028.58     Document Type: Article

References (21)

1. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res. 2000;87: 179-183.
2. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol. 2000;20:1430-1442.
3. Faraci FM, Sobey CG. Role of potassium channels in regulation of cerebral vascular tone. J Cereb Blood Flow Metab. 1998;18:1047-1063.
4. + channels. Stroke. 1997;28:2290-2294.
5. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998;78:53-97.
6. McIntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension: the role of superoxide anion. Hypertension. 1999;34:539-545.
7. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
8. Lassegue B, Sorescu D, Szocs K, et al. Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res. 2001;88:888-894.
9. Didion SP, Faraci FM. Effects of NADH and NADPH on superoxide levels and cerebral vascular tone. Am J Physiol. 2002;282:H688-H695.
10. Paravicini TM, Gulluyan LM, Dusting GJ, et al. Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ Res. 2002;91: 54-61.
11. Sobey CG, Faraci FM. Inhibitory effect of 4-aminopyridine on responses of the basilar artery to nitric oxide. Br J Pharmacol. 1999;126: 1437-1443.
12. Winer J, Jung CK, Shackel I, et al. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999;270:41-49.
13. Redon J, Oliva MR, Tormos C, et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension. 2003;41: 1096-1101.
14. Lacy F, O'Connor DT, Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens. 1998;16:291-303.
15. Di Wang H, Hope S, Du Y, et al. Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. Hypertension. 1999;33:1225-1232.
16. Souza HP, Laurindo FR, Ziegelstein RC, et al. Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control. Am J Physiol. 2001;280:H658-H667.
17. Sobey CG, Heistad DD, Faraci FM. Potassium channels mediate dilatation of cerebral arterioles in response to arachidonate. Am J Physiol. 1998;275:H1606-H1612.
18. Ito D, Murata M, Watanabe K, et al. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke. 2000;31:936-939.
19. Guzik TJ, West NE, Black E, et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation. 2000;102: 1744-1747.
20. Wingler K, Wunsch S, Kreutz R, et al. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med. 2001;31:1456-1464.
21. Mollnau H, Wendt M, Szocs K, et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res. 2002;90:e58-e65.